Poly-L-Glutamic acid (MW 100000)
Poly-L-Glutamic acid (MW 100000) is a synthetic polypeptide with biocompatibility, biodegradability and non-immunogenicity. Poly-L-Glutamic acid is an ideal tumor-targeting polymer carrier. Poly-L-Glutamic acid can be hydrolyzed by cathepsin B during metabolic decomposition.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 25513-46-6
- Fòrmula: (C5H9NO4)x
- Peso molecular:100000 (Average)
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Cathepsin
More
Actividad biológica
Descripciòn
In Vitro
Poly-L-Glutamic acid acts as a covalent carrier for Paclitaxel (TXL) (HY-B0015) to form PG-TXL (CT-2103)[1].
Poly-L-Glutamic acid is used to construct targeted hybrid peptosomes co-loaded with Doxorubicin (HY-15142A) and USPIONs as a theranostic platform for metastatic breast cancer[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 25513-46-6
-
Peso molecular 100000 (Average)
-
Fòrmula (C5H9NO4)x
-
SMILES
OC(CC[C@H](N)C(O)=O)=O.[x]
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[2]. Li C. Poly(L-glutamic acid)--anticancer drug conjugates. Adv Drug Deliv Rev. 2002 Sep 13;54(5):695-713. [Content Brief]
[3]. Hasannia M, et al. Targeted poly(L-glutamic acid)-based hybrid peptosomes co-loaded with doxorubicin and USPIONs as a theranostic platform for metastatic breast cancer. Nanomedicine. 2023 Feb;48:102645. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)